Results for this period
Third quarter1 June 2025–28 February 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stagnation in some demand related to electronic components and semiconductors, soft performance by optical units and optical system products in the Systems Products Business, and a decline following the completion of large projects for the medical industry. While the Company implemented price revisions, productivity improvements and cost controls, personnel and depreciation expenses increased due to investments in human resources and capital expenditures.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 June 2025–28 February 2026 |
| Net Sales | ¥8,190 million (YoY -5.8%) |
| Operating profit | ¥756 million (YoY -13.5%) |
| Ordinary income | ¥827 million (YoY -11.6%) |
| Profit attributable to owners of the parent | ¥534 million (YoY -17.5%) |
| Net income per share | ¥75.47 |
| Equity ratio | End of the current fiscal period 87.5 / End of previous period 86.9 |
| Total assets | ¥20,784 million |
| Net assets | ¥18,295 million |
| Full-year earnings forecast | Net Sales ¥11,695 million (YoY +1.0%) / Operating profit ¥1,220 million (YoY +7.9%) / Ordinary income ¥1,320 million (YoY +4.0%) / Profit attributable to owners of the parent ¥885 million (YoY -10.2%) |
| Annual Dividend Forecast | ¥42 → ¥42（0.0%） |
| Segment revenue | Component Products Business ¥7,013,451 thousand (including intersegment sales) (YoY -5.1%) / Systems Products Business ¥1,248,763 thousand (including intersegment sales) (YoY -9.4%) |
| Segment profit | Component Products Business ¥1,062,856 thousand (YoY -16.7%) / Systems Products Business ¥94,534 thousand (YoY +715.3%) |
| Regional sales | Japan ¥4,917,677 thousand / Americas ¥1,150,463 thousand / Europe ¥658,961 thousand / Asia (excluding Japan) ¥1,253,951 thousand / Other ¥209,010 thousand |
| Depreciation and amortization | ¥335,445 thousand |
| Impairment loss | No applicable items for the cumulative third quarter of the current consolidated fiscal year |
| Breakdown of extraordinary income (loss) | Extraordinary income None (government grants received are shown as “-”) / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Added: 0 companies; excluded: 0 companies (company names not disclosed) |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No (no target participants specified) |
| Issued Shares at Period-End | 7,552,628 |
| Treasury Shares at Period-End | 470,456 |
| Factors Behind Changes in Business Performance | Stagnation in some demand related to electronic components and semiconductors, soft performance by optical units and optical system products in the Systems Products Business, and a decline following the completion of large projects for the medical industry. While the Company implemented price revisions, productivity improvements and cost controls, personnel and depreciation expenses increased due to investments in human resources and capital expenditures. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Some demand related to electronic components and semiconductors remained soft, while the Systems Products Business was affected by a decline following the completion of large projects for the medical industry. Although the Company pursued price revisions, productivity improvements and cost controls, personnel and depreciation expenses increased due to investments in human resources and capital expenditures.